Michniacki, Thomas F. http://orcid.org/0000-0001-8919-5243
Walkovich, Kelly
DeMeyer, Lauren
Saad, Nadine
Hannibal, Mark
Basiaga, Matthew L.
Horst, Kelly K.
Mohan, Smriti
Chen, Liang
Brodeur, Kailey
Du, Yan
Frame, David
Ngo, Sandra
Simoneau, Jillian
Brown, Noah
Lee, Pui Y.
Funding for this research was provided by:
National Institute of Health / National Institute of Arthritis and Musculoskeletal and Skin Diseases (K08-AR074562)
Charles H. Hood Foundation Child Health Research Award
Arthritis National Research Foundation All Arthritis Grant
Article History
Received: 25 May 2022
Accepted: 9 August 2022
First Online: 17 August 2022
Declarations
:
: All experimental studies were approved by the Institutional Review Board at Boston Children’s Hospital. This study was performed in line with the principles of the Declaration of Helsinki.
: Informed consent was provided by participants or legal guardians. The patient’s family additionally provided authorization to report and publish her case.
: No authors have competing interests. Michniacki, Saad, Hannibal, DeMeyer, Brown, Mohan, Lee, Ngo, Simoneau, Chen, Brodeur, Du, Basiaga, Horst: No disclosures. Frame: Research Funding from Jazz Pharmaceuticals. Walkovich: Horizon Pharmaceuticals: Honoraria, Membership on an entity’s Board of Directors or advisory committees; Pharming: Honoraria, Membership on an entity’s Board of Directors or advisory committees; Swedish Orphan Biovitrum AB (Sobi): Consultancy, Honoraria; X4 Pharmaceuticals: Other: Local PI for clinical trial involving mavorixafor and patients with neutropenia.
Free to read: This content has been made available to all.